Pacira Biosciences Inc PCRX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/16/24 EDT
31.51quote price arrow up+1.43 (+4.75%)
Volume
741,138
52 week range
25.33 - 42.63
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close31.51
  • 52 Week High42.63
  • 52 Week High Date05/23/23
  • 52 Week Low25.33
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap1.467B
  • Shares Out46.55M
  • 10 Day Average Volume1.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-6.61

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close31.51
  • 52 Week High42.63
  • 52 Week High Date05/23/23
  • 52 Week Low25.33
  • 52 Week Low Date04/26/24
  • Market Cap1.467B
  • Shares Out46.55M
  • 10 Day Average Volume1.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-6.61

RATIOS/PROFITABILITY

  • EPS (TTM)1.30
  • P/E (TTM)24.32
  • Fwd P/E (NTM)11.31
  • EBITDA (TTM)167.857M
  • ROE (TTM)8.49%
  • Revenue (TTM)681.754M
  • Gross Margin (TTM)73.15%
  • Net Margin (TTM)10.34%
  • Debt To Equity (MRQ)58.32%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pacira Biosciences Inc

 

Profile

MORE
Pacira BioSciences, Inc. is a holding company for Pacira Pharmaceuticals, Inc. The Company's non-opioid treatments include EXPAREL (bupivacaine liposome injectable suspension), which is a long-acting, local analgesic for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), which is an extended-release, intra-articular (IA), corticosteroid injection indicated for OA knee pain, and Iovera, which is a novel handheld device for...
Paul Hastings
Independent Chairman of the Board
Frank Lee
Chief Executive Officer, Director
Daryl Gaugler
Chief Operating Officer
Charles Reinhart III
Chief Financial Officer
Address
5401 West Kennedy Boulevard, Suite 890
Tampa, FL
33609
United States

Top Peers

SYMBOLLASTCHG%CHG
SUPN
Supernus Pharmaceuticals Inc
29.16+0.42+1.46%
ANIP
ANI Pharmaceuticals Inc
63.77-1.05-1.62%
HRMY
Harmony Biosciences Holdings Inc
29.31-0.39-1.31%
COLL
Collegium Pharmaceutical Inc
33.67-0.31-0.91%
AMPH
Amphastar Pharmaceuticals Inc
42.74+0.30+0.71%